Anzeige
Mehr »
Login
Freitag, 14.08.2020 Börsentäglich über 12.000 News von 644 internationalen Medien
News des Tages: Produkt nach 72 Stunden komplett ausverkauft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P2NP ISIN: US83548R1059 Ticker-Symbol: H3D 
Tradegate
13.08.20
16:18 Uhr
2,240 Euro
+0,020
+0,90 %
1-Jahres-Chart
SONNET BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SONNET BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,1602,38013.08.

Aktuelle News zur SONNET BIOTHERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SONNET BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
04.08.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report8
04.08.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million240PRINCETON, NJ / ACCESSWIRE / August 4, 2020 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs...
► Artikel lesen
04.08.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Signs Letter of Intent for Potential Licensing of Neuropathies Asset to New Life Therapeutics273Potential Collaboration in Diabetic Peripheral Neuropathy and Chemotherapy-Induced Peripheral Neuropathy for ASEAN Region $500,000 Non-Refundable Payment to Sonnet on Signing of Letter of Intent Potential...
► Artikel lesen
31.07.Sonnet BioTherapeutics leads healthcare gainers; ThermoGenesis and Edesa Biotech among losers24
20.07.Sonnet BioTherapeutics, Inc.: Sonnet Biotherapeutics Announces Positive Preclinical Results from an Initial Efficacy Study Exploring the Combination of Granulocyte-Macrophage Colony-Stimulating Factor with Interleukins 18 and 12244Data provide proof-of-concept for advancing SON-2014, a bispecific combination of GMcSF and IL-18 The company will further explore the utility of a bispecific combination of GMcSF and IL-12 PRINCETON...
► Artikel lesen
15.07.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics to Present at the 2020 BTIG Virtual Biotechnology Conference255PRINCETON, NJ / ACCESSWIRE / July 15, 2020 / Sonnet BioTherapeutics, Inc., a company developing innovative targeted biologic drugs with enhanced single or bispecific mechanisms, announced today that...
► Artikel lesen
09.07.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report5
20.05.Sonnet BioTherapeutics Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans16
18.05.Sonnet BioTherapeutics reports Q1 results15
18.05.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Holdings Provides Business and Earnings Update321Company successfully completes merger with private Sonnet BioTherapeutics Company Launches Initiative to Explore FHAB Technology in Antiviral Applications PRINCETON, NJ / ACCESSWIRE / May 18, 2020...
► Artikel lesen
18.05.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report3
18.05.Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quaterly Report3
15.05.Sonnet BioTherapeutics Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB5
22.04.Sonnet BioTherapeutics Holdings, Inc. - 10-K/A, Annual Report20
20.04.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report15
15.04.What To Know About The Move In Sonnet BioTherapeutics14
14.04.Sonnet BioTherapeutics up 87% on potential of technology for COVID-1945
14.04.Stock Alert: Sonnet BioTherapeutics Up 150%28
06.04.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Formation of Scientific Advisory Board729PRINCETON, NJ / ACCESSWIRE / April 6, 2020 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a biopharmaceutical company developing innovative, targeted biologic drugs with enhanced single or bispecific...
► Artikel lesen
02.04.RELIEF THERAPEUTICS Holding SA gibt den Abschluss eines Vertrags über den Aktientausch mit Sonnet BioTherapeutics Inc. für den Verkauf ihrer hundertprozentigen Tochtergesellschaft Relief Therapeutics SA bekannt631RELIEF THERAPEUTICS Holding SA (SIX: RLF, "Relief Holding") gibt den Abschluss eines bindenden Vertrags über den Aktientausch (Share Exchange Agreement bzw. "SEA") für die Übernahme durch Sonnet...
► Artikel lesen
Seite:  Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1